91 related articles for article (PubMed ID: 20026648)
21. Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis.
Morbini P; Inghilleri S; Campo I; Oggionni T; Zorzetto M; Luisetti M
Pathol Res Pract; 2011 Sep; 207(9):559-67. PubMed ID: 21798671
[TBL] [Abstract][Full Text] [Related]
22. Fibrotic extracellular matrix activates a profibrotic positive feedback loop.
Parker MW; Rossi D; Peterson M; Smith K; Sikström K; White ES; Connett JE; Henke CA; Larsson O; Bitterman PB
J Clin Invest; 2014 Apr; 124(4):1622-35. PubMed ID: 24590289
[TBL] [Abstract][Full Text] [Related]
23. Potential role of endothelin-1 in pulmonary fibrosis: from the bench to the clinic.
Ross B; D'Orléans-Juste P; Giaid A
Am J Respir Cell Mol Biol; 2010 Jan; 42(1):16-20. PubMed ID: 19717811
[TBL] [Abstract][Full Text] [Related]
24. TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner.
Wygrecka M; Zakrzewicz D; Taborski B; Didiasova M; Kwapiszewska G; Preissner KT; Markart P
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):614-27. PubMed ID: 22771387
[TBL] [Abstract][Full Text] [Related]
25. Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis.
El Agha E; Moiseenko A; Kheirollahi V; De Langhe S; Crnkovic S; Kwapiszewska G; Szibor M; Kosanovic D; Schwind F; Schermuly RT; Henneke I; MacKenzie B; Quantius J; Herold S; Ntokou A; Ahlbrecht K; Braun T; Morty RE; Günther A; Seeger W; Bellusci S
Cell Stem Cell; 2017 Feb; 20(2):261-273.e3. PubMed ID: 27867035
[TBL] [Abstract][Full Text] [Related]
26. Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF).
Antoniou KM; Papadaki HA; Soufla G; Kastrinaki MC; Damianaki A; Koutala H; Spandidos DA; Siafakas NM
Respir Med; 2010 Oct; 104(10):1535-42. PubMed ID: 20483575
[TBL] [Abstract][Full Text] [Related]
27. Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis.
Chilosi M; Doglioni C; Murer B; Poletti V
Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(1):7-18. PubMed ID: 21086900
[TBL] [Abstract][Full Text] [Related]
28. Metalloproteinases in idiopathic pulmonary fibrosis.
Dancer RC; Wood AM; Thickett DR
Eur Respir J; 2011 Dec; 38(6):1461-7. PubMed ID: 21700608
[TBL] [Abstract][Full Text] [Related]
29. Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.
Murray LA; Argentieri RL; Farrell FX; Bracht M; Sheng H; Whitaker B; Beck H; Tsui P; Cochlin K; Evanoff HL; Hogaboam CM; Das AM
Int J Biochem Cell Biol; 2008; 40(10):2174-82. PubMed ID: 18395486
[TBL] [Abstract][Full Text] [Related]
30. Tectorigenin inhibits the in vitro proliferation and enhances miR-338* expression of pulmonary fibroblasts in rats with idiopathic pulmonary fibrosis.
Zhang H; Liu X; Chen S; Wu J; Ye X; Xu L; Chen H; Zhang D; Tan R; Wang Y
J Ethnopharmacol; 2010 Aug; 131(1):165-73. PubMed ID: 20600766
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activator inhibitor-2 (PAI-2) secreted from activated mast cells induces α-smooth muscle actin (α-SMA) expression in dermal fibroblasts.
Kim CD; Sohn KC; Lee SS; Lee JH; Kim S; Lee YH; Ryu EK; Park YS
J Dermatol Sci; 2011 Jun; 62(3):204-6. PubMed ID: 21477997
[No Abstract] [Full Text] [Related]
32. MUCking about in IPF: identification of a novel goblet cell phenotype in pulmonary fibrosis.
Bingle CD
Thorax; 2011 Aug; 66(8):647-8. PubMed ID: 21502093
[No Abstract] [Full Text] [Related]
33. Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors.
Farkas L; Gauldie J; Voelkel NF; Kolb M
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):1-15. PubMed ID: 21057104
[TBL] [Abstract][Full Text] [Related]
34. Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs.
Korfei M; Schmitt S; Ruppert C; Henneke I; Markart P; Loeh B; Mahavadi P; Wygrecka M; Klepetko W; Fink L; Bonniaud P; Preissner KT; Lochnit G; Schaefer L; Seeger W; Guenther A
J Proteome Res; 2011 May; 10(5):2185-205. PubMed ID: 21319792
[TBL] [Abstract][Full Text] [Related]
35. Analysis of fibroblast migration dynamics in idiopathic pulmonary fibrosis using image-based scaffolds of the lung extracellular matrix.
Tisler M; Alkmin S; Chang HY; Leet J; Bernau K; Sandbo N; Campagnola PJ
Am J Physiol Lung Cell Mol Physiol; 2020 Feb; 318(2):L276-L286. PubMed ID: 31774302
[TBL] [Abstract][Full Text] [Related]
36. Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary Fibrosis.
Elowsson Rendin L; Löfdahl A; Åhrman E; Müller C; Notermans T; Michaliková B; Rosmark O; Zhou XH; Dellgren G; Silverborn M; Bjermer L; Malmström A; Larsson-Callerfelt AK; Isaksson H; Malmström J; Westergren-Thorsson G
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426504
[TBL] [Abstract][Full Text] [Related]
37. The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis.
Königshoff M; Wilhelm A; Jahn A; Sedding D; Amarie OV; Eul B; Seeger W; Fink L; Günther A; Eickelberg O; Rose F
Am J Respir Cell Mol Biol; 2007 Dec; 37(6):640-50. PubMed ID: 17630322
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic mechanisms through which Toll-like receptor-9 drives idiopathic pulmonary fibrosis progression.
Hogaboam CM; Murray L; Martinez FJ
Proc Am Thorac Soc; 2012 Jul; 9(3):172-6. PubMed ID: 22802293
[TBL] [Abstract][Full Text] [Related]
39. Treating IPF--all or nothing? A PRO-CON debate.
Behr J; Kolb M; Cox G
Respirology; 2009 Nov; 14(8):1072-81. PubMed ID: 19909457
[TBL] [Abstract][Full Text] [Related]
40. Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway.
Meng J; Zou Y; Hu C; Zhu Y; Peng Z; Hu G; Wang Z; Tao L
Shock; 2012 Nov; 38(5):567-73. PubMed ID: 23042199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
